Tumor transplantation Xenogeneic

Xenotransplantation tumor transplantation is a treatment method in which genetically modified cells or tissues obtained from another organism are introduced into the patient's body. This method allows you to treat cancer, as well as other serious diseases.

Tumor transplantation is one of the most promising cancer treatments because it uses genetic material to create new cells that can replace damaged or missing tissue.

Xenogeneic tumor transplantations were first performed in the 1980s and have since become widespread in medicine. They allow the use of genetically modified tissues and cells obtained from other animals to treat various diseases.

One of the main advantages of xenogeneic tumor transplants is that they can be used to treat patients who are unable to obtain tissue or cells from their own body. This is especially important for patients with serious diseases, such as cancer, that cannot be cured with traditional treatments.

However, xenogeneic tumor transplantations also have their disadvantages. For example, they can cause an immune response in the patient, which can lead to transplant rejection and worsening of the patient's condition. In addition, some tissues and cells may be less compatible with the patient's body than others.

In general, xenogeneic tumor transplantation is a promising method for treating cancer and other serious diseases, but requires further research and development to improve the effectiveness and safety of this treatment method.



Tumor transplantation by xenografting is usually performed in immunosuppressed patients and involves sewing the donor tumor into the skin or other tissues of the recipient for the purpose of transfer and growth. The procedure involves taking a tumor biopsy from another patient's organ and then adding it to the tissue of the diseased body. Tumor xenotranslation is most often performed during bone marrow transplantation, but can also be performed during transplantation of other organs or tissues (for example, skin grafts).

After receiving tissue from a donor with a tumor, a number of steps must be taken to ensure its successful xenotranslation in the recipient's body. During surgery, tissue samples are processed to remove immune cells. It is also necessary to pre-treat the recipient's stem cells with immunosuppressants to prevent rejection reactions and suppress the immune response. After transplantation, tissue samples are replaced in the recipient through surgery, thereby allowing the tumor cells to be transferred into the body. Due to